OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-10-31-accounts

Charity registration number: 262587

The Plymouth and Cornwall Cancer Fund

Annual Report and Financial Statements for the Year Ended 31 October 2024

The Plymouth and Cornwall Cancer Fund

Contents (continued)

Trustees' Report 1 to 7
Reference and Administrative Details 1
Independent Examiner's Report 8
Statement of Financial Activities 9
Balance Sheet 10
Notes to the Financial Statements 11 to 26

The Plymouth and Cornwall Cancer Fund

Trustees' Report

Reference and Administrative Details

Chair Mrs S Aspley
Ms S Dennison, Vice-chair
Trustees Dr A Smith
Mrs J Cole
Mrs J Bewes, Treasurer
Miss A N O'Connor
Mr P W Harker
Mr R C Laney
Mr C Bowen
Mr A P Shute
Secretary Mr P W Harker
Charity Registration Number 262587
Principal Office 80A Hyde Park Road
Mutley
Plymouth
PL3 4RQ
Independent Examiner Matthew Keane ACCA
Westcotts (SW) LLP
Plym House
3 Longbridge Road
Marsh Mills
Plymouth
Devon
PL6 8LT

Page 1

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

The trustees present the annual report together with the financial statements of the charity for the year ended 31 October 2024.

Chair's report

This year has seen another successful year for Plymouth and Cornwall Cancer Fund, with encouraging indications that the charity is being recognised more widely across the region.

With the support of the public, staff and volunteers, our shops in Yelverton and Hyde Park Rd in Plymouth have again increased their turnovers, building on the success of previous years. The income from our shops proves the mainstay of our ability to support improvements to local cancer care.

During the year we have approved funding for two sizeable grants, as well as supporting educational and relief of hardship grants. It was agreed to repeat funding to build on the success of previous Clinical Nurse Specialist development appointments at Derriford Hospital. At the end of year, Trustees agreed to support a local Lung Cancer project aimed at improving the management of these patients.

Fundraising has gone from strength to strength. This year, large events such as the Yelverton Art Festival, Seth Lakeman gig and Beau’s Fashion Show all boosted funds significantly. But no less important and appreciated are smaller events such as raffles, craft sales and local group fundraising, all contribute.

The Trustees made the decision that it is in the Plymouth and Cornwall Cancer Fund’s best interests to change to a different structure. To this end, the process of conversion is in progress for the charity to convert to a Charitable Incorporated Organisation (CIO).

I want to take this opportunity to extend my personal thanks to everyone involved. Trustees, Staff, loyal volunteers and also all our supporters in the community. Without them, we would not be able to provide the support for local people affected by cancer, which we believe is so important.

Sara J Aspley PCCF Chair

Page 2

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

Governance, decision-making and recruitment and appointment of trustee directors

The fund's governing constitution was adopted on 14 October 1971 and amended on 15 August 1973. The fund is a registered charity. New trustees are appointed on the nomination of the existing Trustees. Not more than one third of Trustees should be an employee. Appointments are made after taking into consideration the specific skills and knowledge of the appointee and the requirements of the board as a whole.

The Trustees have complied with their duty and with due regard to the guidance on public benefit given by the Charity Commission when exercising any powers or duties to which the guidance was relevant.

New Trustees are briefed on their legal obligations under charity law and the Trust deed. They are informed about the decision-making process and familiarised with the business plan and financial performance of the Charity. As soon as practical, new Trustees are introduced to the key employees. Specific training of Trustees is addressed as and when matters arise or a particular area is identified. The Trustees normally meet formally four times a year.

Objectives and activities undertaken

The objectives of Plymouth and Cornwall Cancer Fund are;

To achieve these objectives, we have;

~ Assistance towards travel costs to attend for treatment, additional clothing, accommodation or utility bills are the type of assistance sought. These requests are made to the Charity through the Macmillan Mustard Tree Support Centre at Derriford Hospital where full financial assessments are made prior to application.

Treasurer's remarks

The financial performance of our Charity has improved this year in part due to the increased income at both the Hyde Park and Yelverton shop.

Reserves

At the year-end reserves were £241,670 (an increase since last year - £191,946). Money spent on generating funds, grants and support costs is £103,717 and the charity has currently committed funds of £56,662 to grants (see note 20). Therefore, the trustees consider the level of reserves are appropriate to cushion existing activities from unexpected fluctuations in incoming resources and enable the charity to continue to function effectively.

Page 3

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

Incoming Resources

The incoming resources in the year was £141,877. The income arose from donations £14,358; investment income £9,519 and charity shops income, £116,000. Legacies were received of £2,000 during the year. The combined shops income has increased from the previous year as this was the first full year of trading for the shop at Yelverton.

Resources Expended

The resources expended in the year totalled £103,717, of which grants are £20,467. The remainder of the expenditure was in line with the previous year costs of generating funds which is made up of Charity shop expenditure, fundraising costs and support costs.

The charity remains in a good financial position to meet its' aims and objectives.

Investment policy

Responsible Person - Treasurer

Introduction

The Charity's income fluctuates due to varying levels of donations and legacies.

The Trustees of the Charity have delegated preliminary decision making on investment matters to the investment committee; this comprises of the Chairman, Vice-Chairman, Honorary Secretary and Honorary Treasurer.

The investment committee has appointed an independent professional investment adviser to provide guidance on asset allocation, investment manager selection and ongoing performance analysis.

Investment Policy review and investment decisions will be taken to the Trustees for approval.

The nominated first signatory will be the PCCF Treasurer, and when unavailable will be the Honorary Secretary or Chairman

1. Investment Objectives

The Charity seeks to produce the best financial return within an acceptable level of risk.

All income streams from investments and deposits are to be used by the trustees to help carry out their charitable objectives on behalf of beneficiaries.

The investment objective for the long-term reserves is to generate capital growth in excess of inflation over the long term.

The investment objective for the short-term reserves is to preserve the capital value with a minimum level of risk.

Assets should (wherever possible) be readily available to meet unanticipated cash flow requirements.

2. Risk

The key risk to the long-term reserves is inflation and the assets should be invested to mitigate this risk over the long term.

The Trustees understand that this is likely to mean that investments will be concentrated in real assets and the capital value will fluctuate.

The long-term reserves should be widely diversified by asset class, geographical and individual stock exposure. The investment committee has commissioned an independent professional investment adviser to recommend a suitable asset allocation strategy and to review this annually.

Page 4

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

The short-term reserves are held to provide financial security and may be required at short notice. As such, capital volatility cannot be tolerated and investment of these assets should be focused on security and accessibility.

3. Liquidity Requirements

The Trustees consider that the sum of at least £50,000 should be retained as free reserves to enable them to meet any future urgent requests rapidly.

This policy is reviewed annually and reported to members at each AGM.

4. Time Horizon

The Charity has divided its reserves into those expected to be held for a long-time horizon and those that may be needed in the short term.

5. Ethical Investment Policy

The trustees have decided to publish their ethical investment policy as follows:

In general, our trustees are obliged to consider the type of investment and avoid investing in any particular business that would for practical reasons conflict with the aims of Plymouth and Cornwall Cancer Fund or that might hamper the work of Plymouth and Cornwall Cancer Fund.

Specifically, the trustees have considered such types of businesses for their long-term restricted and unrestricted funds and have decided to:

exclude investment in companies which derive more than 10% of revenue from the tobacco industry on the grounds that these could fundamentally conflict with the Charity's aims as a cancer support charity.

This applies to any direct investments in equities, corporate debt, property or pooled investment funds.

The trustees will also bear this in mind when considering its selection of banks and other deposit holding institutions.

Pooled funds are funds in which a number of different investors invest. Because Plymouth and Cornwall Cancer Fund's specific ethical investment policy may not be able to be applied fully, or at all, in investments in pooled funds and indirect vehicles, it is essential that parameters are set for the use of pooled funds and indirect vehicles.

Any investment manager or adviser will be briefed accordingly of this ethical investment policy appendix (in conjunction with our investment policy) before being offered any contract or mandate to provide investment services or advice to our charity.

6. Management, Reporting and Monitoring

Long Term Reserves

The investment committee has appointed an independent professional investment adviser to carry out a process of investment manager selection.

The long-term reserves are invested in a blend of widely diversified Common Investment Funds (CIFs), Common Authorised Investment Funds (CAIFs) or retail investment funds, known as open ended investment company shares (OEICs) and/or unit Trusts (UTs) with suitable ethical investment policies in place. All funds are to be UK domiciled and regulated by the Financial Conduct Authority.

The value of the Charity's long-term reserves will be monitored at least annually by the investment committee.

Page 5

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

An independent professional investment review is commissioned annually to analyse financial return, asset allocation and volatility and is presented to the investment committee.

Short Term Reserves

The investment committee manages the Charity's short-term cash deposit reserves. The investment committee monitors the short-term reserves at least annually.

7. Approval and Review

This Investment Policy Statement was prepared by the investment committee of the Plymouth and Cornwall Cancer Fund to provide a framework for the management of its reserves. It will be reviewed every three years to ensure its continuing appropriateness.

Approval Date: 25.01.22 (Minute No 1573)

Review Date: 2025

Grant making

Grants will be considered that:

To support your application, healthcare professionals and staff caring for patients will need to provide the following:

If possible. all grant applications should be considered by the full Committee of Trustees, If a shorter timescale for a decision is needed e.g., the date for a study day is before the next scheduled Committee meeting, a decision can be made by three or more officers.

A letter indicating decision to be sent to the applicant with copy sent to the head of relevant department.

Any decisions taken between Committee meetings will be recorded at the next meeting. Electronic records are kept for minimum of seven years. All hard copy records and relevant information are kept for seven years in a secure place. Any personal information held is not shared with any third party without gaining permission from the individual.

Hardship Grants

The PCCF will consider requests from local people with cancer or those that care for them, under the care of Derriford Hospital, Plymouth or other health organisations within its catchment area. This includes requests for:

Page 6

The Plymouth and Cornwall Cancer Fund

Trustees' Report (continued)

How to apply:

Applications for financial assistance should include:

On receipt of a grant application, approval will be sought from two Officers or Trustees, up to a maximum total payment of £500 per Applicant. Sometimes, applications for financial support come in instalments and grants can be approved up to £250 initially, and to up to a maximum total payment of £500 per Applicant.

Requests that exceed a total of £500 will be considered by at least three Officers before payment. A letter of confirmation of PCCF decision is sent to the applicant (with Information Leaflet) with payment and an email to the Health Professional/Macmillan Financial Advisor who made the application on the patient' s/patient's family behalf (using patient's initials only). When providing information to Trustees, the identity of an applicant is kept confidential, and only initials and place of residence to be used.

Copies of applications, decision letters and a copy of the cheque are kept for 7 years in a secure place, either as hard copies or electronically.

Electronic records are kept and, on a password, protected computer, using applicant's initials or reference number only to protect personal information.

Any personal information held is not shared with any third party without gaining permission from the individual.

The annual report was approved by the trustees of the charity on .................... and signed on its behalf by:

......................................... Mrs S Aspley Chairman

......................................... Mrs J Bewes Trustee

Page 7

The Plymouth and Cornwall Cancer Fund

Independent Examiner's Report to the trustees of The Plymouth and Cornwall Cancer Fund

I report to the trustees on my examination of the accounts of The Plymouth and Cornwall Cancer Fund for the year ended 31 October 2024.

Responsibilities and basis of report

As the charity trustees of The Plymouth and Cornwall Cancer Fund you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).

I report in respect of my examination of the The Plymouth and Cornwall Cancer Fund's accounts carried out under section 145 of the 2011 Act and in carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner’s statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of The Plymouth and Cornwall Cancer Fund as required by section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a ‘true and fair view' which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

......................................

Matthew Keane ACCA

Westcotts (SW) LLP Plym House 3 Longbridge Road Marsh Mills Plymouth Devon PL6 8LT

Date:.............................

Page 8

The Plymouth and Cornwall Cancer Fund

Statement of Financial Activities for the Year Ended 31 October 2024

Note
Income and Endowments from:
Donations and legacies
2
Other trading activities
3
Investment income
4
Total income
Expenditure on:
Raising funds
5
Charitable activities
6
Total expenditure
Gains/losses on investment
assets
Net income
Net movement in funds
Reconciliation of funds
Total funds brought forward
Total funds carried forward
18		 Unrestricted
funds
£
16,358
116,000
9,519
141,877
(74,392)
(29,325)
(103,717)
10,161
48,321
48,321
165,945
214,266		 Restricted
funds
£
-
-
-
-
-
-
-
1,403
1,403
1,403
26,001
27,404		 Total
2024
£
16,358
116,000
9,519
141,877
(74,392)
(29,325)
(103,717)
11,564
49,724
49,724
191,946
241,670		 Total
2023
£
23,924
83,413
8,134
115,471
(64,910)
(49,764)
(114,674)
488
1,285
1,285
190,661
191,946

All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2023 is shown in note 18.

The notes on pages 11 to 26 form an integral part of these financial statements. Page 9

The Plymouth and Cornwall Cancer Fund

(Registration number: 262587) Balance Sheet as at 31 October 2024

Note
Fixed assets
Tangible assets
12
Investments
13
Current assets
Debtors
14
Cash at bank and in hand
15
Creditors: Amounts falling due within one year
16
Net current assets
Net assets
Funds of the charity:
Restricted income funds
Restricted funds
Unrestricted income funds
Unrestricted funds
Total funds
18		 2024
£
1,430
155,940
157,370
2,399
83,861
86,260
(1,960)
84,300
241,670
27,404
214,266
241,670		 2023
£
1,948
145,150
147,098
1,619
45,040
46,659
(1,811)
44,848
191,946
26,001
165,945
191,946

The financial statements on pages 9 to 26 were approved by the trustees, and authorised for issue on .................... and signed on their behalf by:

......................................... Mrs S Aspley Chair

......................................... Mrs J Bewes Trustee

The notes on pages 11 to 26 form an integral part of these financial statements. Page 10

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024

1 Accounting policies

Statement of compliance

The financial statements have been prepared in accordance with the second edition of the Charities Statement of Recommended Practice issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102) and the Charities Act 2011.

Basis of preparation

The Plymouth and Cornwall Cancer Fund meets the definition of a public benefit entity under FRS 102. The accounts (financial statements) have been prepared under the historical cost convention with items recognised at cost or transaction value unless otherwise stated in the relevant note(s) to these accounts.

Going concern

The trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern.

Income and endowments

Voluntary income including donations, gifts, legacies and grants that provide core funding or are of a general nature is recognised when the charity has entitlement to the income, it is probable that the income will be received and the amount can be measured with sufficient reliability.

Donations and legacies

Donations and legacies are recognised on a receivable basis when receipt is probable and the amount can be reliably measured.

Investment income

Dividends are recognised once the dividend has been declared and notification has been received of the dividend due.

Expenditure

All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs.

Raising funds

These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.

Page 11

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

Charitable activities

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.

Grant provisions

Provisions for grants are made when the intention to make a grant has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable.

Support costs

Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources, for example, allocating property costs by floor areas, or per capita, staff costs by the time spent and other costs by their usage.

Taxation

The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

Tangible fixed assets

Individual fixed assets are initially recorded at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation and amortisation

Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:

Asset class

Office Equipment

Depreciation method and rate 25% straight line

Fixed asset investments

Fixed asset investments, other than programme related investments, are included at market value at the balance sheet date. Realised gains and losses on investments are calculated as the difference between sales proceeds and their market value at the start of the year, or their subsequent cost, and are charged or credited to the Statement of Financial Activities in the period of disposal.

Unrealised gains and losses represent the movement in market values during the year and are credited or charged to the Statement of Financial Activities based on the market value at the year end.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Page 12

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

Fund structure

Unrestricted income funds are general funds that are available for use at the trustees discretion in furtherance of the objectives of the charity.

Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose.

Pensions and other post retirement obligations

The charity operates a defined benefit pension scheme.Typically defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.

The liability recognised in the Balance Sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the reporting date minus the fair value of plan assets. The defined benefit obligation is measured using the projected unit credit method. The present value of the defined benefit obligation is determined by discounting the estimated future payments by reference to market yields at the reporting date on high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms to maturity approximating to the terms of the related pension liability.

Actuarial gains and losses are charged or credited to other comprehensive income in the period in which they arise.

Financial instruments

Classification

Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities.

Page 13

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

Recognition and measurement

All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Financial assets and liabilities are only offset in the statement of financial position when, and only when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires.

Page 14

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

2 Income from donations and legacies

Donations and legacies;
Donations from companies
Donations from individuals
Legacies
3
Income from other trading activities
Trading income;
Shop income from sale of donated goods and
services
4
Investment income
Interest receivable and similar income;
Interest receivable on bank deposits
7IM Investment Platform
5
Expenditure on raising funds
Fundraising costs
Charity shop costs
Staff Costs
Investment management costs		 Unrestricted
funds
General
£
3,900
10,458
2,000
16,358
Unrestricted
funds
General
£
116,000
116,000
Unrestricted
funds
General
£
774
8,745
9,519
Direct costs
£
376
34,504
37,979
1,533
74,392		 Total
2024
£
3,900
10,458
2,000
16,358
Total
funds
£
116,000
116,000
Total
2024
£
774
8,745
9,519
Total
2024
£
376
34,504
37,979
1,533
74,392		 Total
2023
£
-
23,924
-
23,924
Total
2023
£
83,413
83,413
Total
2023
£
364
7,770
8,134
Total
2023
£
354
32,068
32,488
-
64,910

Page 15

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

a) Fundraising Costs

Telephone and fax
Printing, postage and stationery
Events
Sundry expenses
Just Giving fees		 Unrestricted
funds
General
£
-
-
126
38
212
376		 Total
2024
£
-
-
126
38
212
376		 Total
2023
£
27
96
(5)
20
216
354

b) Charity shop

Rent
Rates
Light, heat and power
Insurance
Premises costs
Equipment repairs and renewals
Telephone and fax
Printing, postage and stationery
Sundry expenses
Bank charges		 Unrestricted
funds
General
£
23,122
2,045
3,011
224
-
2,265
1,567
-
1,158
1,112
34,504		 Total
2024
£
23,122
2,045
3,011
224
-
2,265
1,567
-
1,158
1,112
34,504		 Total
2023
£
18,265
3,014
2,915
842
178
4,618
498
138
878
722
32,068

Page 16

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

c) Investment management costs

Other investment management costs;
Portfolio management costs
Loss on disposal of investment assets
6
Expenditure on charitable activities
Grant funding of activities
Staff costs
Allocated support costs
Governance costs
Grant funding of activities
Staff costs
Allocated support costs		 Unrestricted
funds
General
£
36,167
2,215
6,516
44,898		 Unrestricted
funds
General
£
1,146
387
1,533
Unrestricted
funds
General
£
20,467
2,445
6,412
1
29,325
Restricted
funds
£
4,866
-
-
4,866		 Total
2024
£
1,146
387
1,533
Total
2024
£
20,467
2,445
6,412
1
29,325
Total
2023
£
41,033
2,215
6,516
49,764

Page 17

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

7 Analysis of support costs

Support costs allocated to charitable activities

Support costs allocated to charitable activities
Support costs
Communications and IT
General office
Governance costs
Insurance
Printing, postage and stationery
Bank charges
Depreciation of office equipment		 Other
support
costs
£
-
1,318
-
2,654
1,108
527
184
621
6,412		 Total
2024
£
-
1,318
-
2,654
1,108
527
184
621
6,412		 Total
2023
£
13
2,126
213
2,088
470
356
723
527
6,516

8 Grant-making

Analysis of grants

Analysis of grants
Analysis
Plymouth Hospitals NHS Trust
Hardship Costs		 Grants to institutions
2024
£
2023
£
17,111
36,725
-
-
17,111
36,725		 Grants to individuals
2024
£
2023
£
-
-
3,356
4,308
3,356
4,308
4,308

The support costs associated with grant-making are £Nil (31 October 2023 - £14,622).

9 Trustees remuneration and expenses

No trustees, nor any persons connected with them, have received any remuneration from the charity during the year.

No trustees have received any reimbursed expenses or any other benefits from the charity during the year.

Page 18

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

10 Staff costs

The aggregate payroll costs were as follows:

The aggregate payroll costs were as follows:
2024 2023
£ £
Staff costs during the year were:
Wages and salaries 40,115 34,499
Pension costs 309 204
40,424 34,703
The monthly average number of persons (including senior management / leadership team) employed
by the charity during the year was as follows:
2024 2023
No No
Average head count 4 2
No employee received emoluments of more than £60,000 during the year
11 Independent examiner's remuneration
2024 2023
£ £
Other fees to examiners
Examination-related assurance services 755 700

Page 19

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

12 Tangible fixed assets

12 Tangible fixed assets
Cost
At 1 November 2023
Additions
At 31 October 2024
Depreciation
At 1 November 2023
Charge for the year
At 31 October 2024
Net book value
At 31 October 2024
At 31 October 2023		 Furniture
and
equipment
£
4,773
103
4,876
2,825
621
3,446
1,430
1,948		 Total
£
4,773
103
4,876
2,825
621
3,446
1,430
1,948

Page 20

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

13 Fixed asset investments

13 Fixed asset investments
Other investments
Other investments
Cost or Valuation
At 1 November 2023
Fair value movement
Disposals
At 31 October 2024
Net book value
At 31 October 2024
At 31 October 2023
The total cost of the investments made was £138,729.		 2024
£
155,940
Listed
investments
£
145,150
11,177
(387)
155,940
155,940
145,150		 2023
£
145,150
Total
£
145,150
11,177
(387)
155,940
155,940
145,150

14 Debtors

Prepayments
Other debtors
15 Cash and cash equivalents
Cash at bank		 2024
£
880
1,519
2,399
2024
£
83,861		 2023
£
898
721
1,619
2023
£
45,040

Page 21

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

16 Creditors: amounts falling due within one year

16 Creditors: amounts falling due within one year
Other taxation and social security
Other creditors
Accruals		 2024
£
196
-
1,764
1,960		 2023
£
127
4
1,680
1,811

17 Obligations under leases and hire purchase contracts

Yelverton Shop Rent

Total future minimum lease payments under non-cancellable operating leases are as follows:

Land and buildings
Within one year
Between one and five years
After five years		 2024
£
7,500
32,917
27,208
67,625		 2023
£
7,500
32,917
34,708
75,125

Page 22

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

18 Funds

Unrestricted funds
General
General Funds
Restricted funds
Research funds
Total funds
Unrestricted funds
General
General Funds
Restricted funds
Research funds
Total funds		 Balance at
1
November
2023
£
Incoming
resources
£
Resources
expended
£

165,945
141,877
(103,716)
26,001
-
-
191,946
141,877
(103,716)
Balance at
1
November
2022
£
Incoming
resources
£
Resources
expended
£
160,095
115,402
(109,808)
30,566
69
(4,866)
190,661
115,471
(114,674)		 Other
recognised
gains/
(losses)
£
10,161
1,403
11,564
Other
recognised
gains/
(losses)
£
256
232
488		 Balance at
31 October
2024
£
214,267
27,404
241,671
Balance at
31
October
2023
£
165,945
26,001
191,946

Restricted funds are for use in research into finding a cure for cancer.

Page 23

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

19 Analysis of net assets between funds

19 Analysis of net assets between funds
Tangible fixed assets
Fixed asset investments
Current assets
Current liabilities
Total net assets
Tangible fixed assets
Fixed asset investments
Current assets
Current liabilities
Total net assets		 Unrestricted
funds
General
£
1,430
134,272
80,524
(1,960)
214,266
Unrestricted
funds
General
£
1,948
124,885
40,923
(1,811)
165,945		 Restricted
funds
£
-
21,668
5,736
-
27,404
Restricted
funds
£
-
20,265
5,736
-
26,001		 Total funds
at 31
October
2024
£
1,430
155,940
86,260
(1,960)
241,670
Total funds
at 31
October
2023
£
1,948
145,150
46,659
(1,811)
191,946

Page 24

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

20 Analysis of net assets between funds

Tangible fixed assets
Fixed asset investments
Current assets
Current liabilities
Total net assets
Tangible fixed assets
Fixed asset investments
Current assets
Current liabilities
Total net assets		 Unrestricted
funds
General
£
1,430
134,272
80,524
(1,960)
214,266
Unrestricted
funds
General
£
1,948
124,885
40,923
(1,811)
165,945		 Restricted
funds
£
-
21,668
5,736
-
27,404
Restricted
funds
£
-
20,265
5,736
-
26,001		 Total funds
at 31
October
2024
£
1,430
155,940
86,260
(1,960)
241,670
Total funds
at 31
October
2023
£
1,948
145,150
46,659
(1,811)
191,946

21 Capital commitments and future funding commitments

General funds
18M Development CNS Post
Teenage and Young Adults with Cancer CNS
Restricted funds - Research
QOL Lung Cancer Project		 Payable within
12 months
£
4,862
42,500
47,362
Payable within
12 months
£
9,300
9,300

There were no capital commitments or future funding commitments payable over 12 months.

Page 25

The Plymouth and Cornwall Cancer Fund

Notes to the Financial Statements for the Year Ended 31 October 2024 (continued)

22 Related party transactions

There were no related party transactions in the year.

Page 26